GALT Competitors & Alternatives
Compare Galectin Therapeutics Inc with similar stocks in the same industry
Biotechnology
GALT
Main Stock$2.35
Tradestie Score
54
Market Cap
$267.77M
Analyst Upside
+368.1%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CABA
Cabaletta Bio, Inc. Common Stock
|
$3.58
|
$211.28M | - | 52 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$8.19
|
$211.22M | - | 62 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.42
|
$202.58M | - | 53 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$17.98
|
$199.71M | - | 47 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$13.74
|
$170.45M | - | 53 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$4.92
|
$158.43M | - | 53 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.44
|
$133.50M | - | 53 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$18.85
|
$110.20M | - | 48 | Compare |
|
LITS
Lite Strategy, Inc. Common Stock
|
$0.87
|
$91.28M | - | 45 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.33
|
$71.69M | - | 53 | Compare |
More GALT Analysis
Data updated: Jun 03, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry